Publications by authors named "Mike F Burbridge"

Claim this Profile
T
The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy.
Céline Clémenson, Cyrus Chargari, Winchygn Liu, Michele Mondini, Charles Ferté, Mike F Burbridge

Mol Cancer Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.
Federica Guffanti, Rosaria Chilà, Ezia Bello, Massimo Zucchetti, Monique Zangarini, Mike F Burbridge

Neoplasia· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab.
Mike F Burbridge, Céline J Bossard, Carine Saunier, Imre Fejes, Alain Bruno

Mol Cancer Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Only a subset of Met-activated pathways are required to sustain oncogene addiction.
Andrea Bertotti, Mike F Burbridge, Stefania Gastaldi, Francesco Galimi, Davide Torti

Sci Signal· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Only a subset of Met-activated pathways are required to sustain oncogene addiction.
Andrea Bertotti, Mike F Burbridge, Stefania Gastaldi, Francesco Galimi, Davide Torti

Sci Signal· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional in vitro anglogenesis in the rat aortic ring model.
David C West, Mike F Burbridge

Methods Mol Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease in survival threshold of quiescent colon carcinoma cells in the presence of a small molecule integrin antagonist.
Mike F Burbridge, Virginie Venot, Patrick J Casara, Françoise Perron-Sierra, John A Hickman

Mol Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis